Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Century Therapeutics, Inc.”

5 pharma patents match "Century Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "Century Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “Century Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12269888

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  2. US 11883432

    Chimeric antigen receptor system with adaptable receptor specificity

    Century Therapeutics, Inc. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted

  3. US 11661459

    Artificial cell death polypeptide for chimeric antigen receptor and uses thereof

    Century Therapeutics, Inc. · Granted May 30, 2023 · Expires May 25, 2043

    granted

  4. US 11401246

    Triazole glycolate oxidase inhibitors

    Century Therapeutics, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  5. US 11236056

    Small molecules and methods of reducing injuries caused by radiation or chemicals

    21ST CENTURY THERAPEUTICS, INC. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.